Literature DB >> 16514188

Dissociation of oocyte nuclear and cytoplasmic maturation by the addition of insulin in cultured bovine antral follicles.

A A Fouladi-Nashta1, K H S Campbell.   

Abstract

Follicles of 4-8 mm in diameter were dissected from ovaries and cultured in Waymouth culture medium in the presence or absence of insulin (5 mug/ml) at 39 degrees C in a humidified atmosphere of 45% O2, 5% CO2 and 50% N2 for 24 h. Following follicle culture, the oocytes were collected and examined for developmental potential, total protein profile and ultrastructural aspects. Oocytes aspirated directly from follicles of the same size were used as controls. Addition of insulin to the follicle culture medium significantly reduced expression of the low molecular weight insulin-like growth factor-binding proteins (IGFBPs) in the follicular fluid, and significantly reduced the cleavage rate of subsequently matured and fertilised oocytes (0.52 vs 0.61). However, there were no differences in the proportion of cleaved embryos which developed to the blastocyst stage (0.30 vs 0.28), nor embryo quality as assessed by total cell number (137 +/- 8.53 vs 124.6 +/- 6.95). The total protein profiles of immature oocytes recovered after 24 h of follicle culture were compared by PAGE. There were marked differences between the two groups, unmatured oocytes recovered from the insulin-positive follicle group showed a protein pattern similar to that of matured oocytes. In addition, examination of ultrastructural features by transmission electron microscopy indicated that oocytes from follicles cultured in the presence of insulin undergo many of the cytoplasmic changes associated with oocyte maturation. In conclusion, follicle culture in the presence of insulin is beneficial for follicular survival and significantly reduces cleavage but has no detrimental effects on the development of cultured embryos. However, many of the cytoplasmic changes associated with oocyte maturation occur prior to the induction of nuclear maturation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16514188     DOI: 10.1530/rep.1.00581

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  6 in total

1.  Effects of propylene glycol or elevated luteinizing hormone during follicle development on ovulation, fertilization, and early embryo development.

Authors:  Katherine S Hackbart; Robb W Bender; Paulo D Carvalho; Lais M Vieira; Ana R Dresch; Jerry N Guenther; Hidir Gencoglu; Anibal B Nascimento; Randy D Shaver; Milo C Wiltbank
Journal:  Biol Reprod       Date:  2017-10-01       Impact factor: 4.285

2.  Effect of insulin supplementation on in vitro maturation of pre-antral follicles from adult and pre-pubertal mice.

Authors:  Amar Nath; Bilal Ahmad Hakim; Singh Rajender; Kavita Singh; Monika Sachdev; Rituraj Konwar
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-03-08       Impact factor: 2.416

3.  Insulin concentrations used in in vitro embryo production systems: a pilot study on insulin stability with an emphasis on concentrations measured in vivo.

Authors:  Denise Laskowski; Ylva Sjunnesson; Hans Gustafsson; Patrice Humblot; Göran Andersson; Renée Båge
Journal:  Acta Vet Scand       Date:  2016-10-20       Impact factor: 1.695

4.  Using exosomal miRNAs extracted from porcine follicular fluid to investigate their role in oocyte development.

Authors:  Junhe Hu; Jinyi Dong; Zhi Zeng; Juan Wu; Xiansheng Tan; Tao Tang; Jiao Yan; Chenzhong Jin
Journal:  BMC Vet Res       Date:  2020-12-14       Impact factor: 2.741

5.  Endometrium On-a-Chip Reveals Insulin- and Glucose-induced Alterations in the Transcriptome and Proteomic Secretome.

Authors:  Tiago H C De Bem; Haidee Tinning; Elton J R Vasconcelos; Dapeng Wang; Niamh Forde
Journal:  Endocrinology       Date:  2021-06-01       Impact factor: 4.736

6.  Quantitative bioluminescence imaging of transgene expression in intact porcine antral follicles in vitro.

Authors:  Song-yi Jung; Scott T Willard
Journal:  Reprod Biol Endocrinol       Date:  2014-01-30       Impact factor: 5.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.